• Science and Research

  Motif Bio, Lamellar to Test New Therapeutic Combo for CF Lung Infections

  Posted by Cystic Fibrosis News Moderator on May 10, 2019 at 7:21 pm

  

  Click here to read about the collaboration between Motif Bio and Lamellar Biomedical to test a new therapeutic combination for treating lung infections in people with cystic fibrosis.

  What do you think of this news?

  Cystic Fibrosis News Moderator replied 6 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply